Holen Sie sich die Stockscreener-App
10.68
0.28%
-0.03
Vorhandelsmarkt:
10.40
-0.28
-2.62%
Schlusskurs vom Vortag:
$10.71
Offen:
$10.56
24-Stunden-Volumen:
126.10K
Relative Volume:
0.37
Marktkapitalisierung:
$698.13M
Einnahmen:
$555.06M
Nettoeinkommen (Verlust:
$-39.48M
KGV:
-17.80
EPS:
-0.6
Netto-Cashflow:
$29.05M
1W Leistung:
-2.82%
1M Leistung:
+15.09%
6M Leistung:
+40.71%
1J Leistung:
+142.73%
1-Tages-Spanne:
$10.52
$10.72
1-Wochen-Bereich:
$10.29
$11.15
52-Wochen-Spanne:
$3.90
$14.38
Bioventus Inc Stock (BVS) Company Profile
Firmenname
Bioventus Inc
Sektor
Branche
Telefon
(919) 474-6700
Adresse
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM
Vergleichen Sie BVS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BVS
Bioventus Inc
|
10.68 | 698.13M | 555.06M | -39.48M | 29.05M | -0.60 |
|
ABT
Abbott Laboratories
|
131.44 | 227.98B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.98 | 156.20B | 16.75B | 1.85B | 1.89B | 1.25 |
|
SYK
Stryker Corp
|
390.48 | 148.86B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
91.20 | 116.94B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
70.91 | 41.82B | 6.60B | 4.16B | 490.10M | 6.93 |
Bioventus Inc Stock (BVS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-17 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2023-12-07 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-08-09 | Hochstufung | Craig Hallum | Hold → Buy |
| 2022-11-22 | Herabstufung | Craig Hallum | Buy → Hold |
| 2022-11-09 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-11-09 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2022-03-15 | Eingeleitet | Craig Hallum | Buy |
| 2021-11-15 | Fortgesetzt | Morgan Stanley | Overweight |
| 2021-11-10 | Fortgesetzt | JP Morgan | Overweight |
| 2021-07-01 | Herabstufung | Goldman | Buy → Neutral |
| 2021-03-08 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-03-08 | Eingeleitet | Goldman | Buy |
| 2021-03-08 | Eingeleitet | JP Morgan | Overweight |
| 2021-03-08 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Bioventus Inc Aktie (BVS) Neueste Nachrichten
(BVS) Investment Report - Stock Traders Daily
Spire Wealth Management Invests $402,000 in Bioventus Inc. (NYSE:BVS) - MarketBeat
With 32% ownership, Bioventus Inc. (NASDAQ:BVS) has piqued the interest of institutional investors - Yahoo Finance
Learn to Evaluate (BVS) using the Charts - Stock Traders Daily
JPMorgan Chase & Co. Increases Holdings in Bioventus Inc. (NYSE:BVS) - MarketBeat
JPMorgan Chase & Co. Raises Position in Bioventus Inc. (NYSE:BVS) - Defense World
How to Take Advantage of moves in (BVS) - Stock Traders Daily
Barclays PLC Purchases 9,854 Shares of Bioventus Inc. (NYSE:BVS) - Defense World
Wall Street Analysts Think Bioventus (BVS) Could Surge 26.03%: Read This Before Placing a Bet - MSN
Reed Smith represents Bioventus on its sale of Advanced Rehabilitation to Accelmed Partners - Reed Smith LLP
Bioventus CEO Robert Claypoole sells $261,952 in stock By Investing.com - Investing.com Nigeria
Robert E. Claypoole Sells 28,786 Shares of Bioventus Inc. (NYSE:BVS) Stock - MarketBeat
Bioventus CEO Robert Claypoole sells $261,952 in stock - Investing.com
Where are the Opportunities in (BVS) - Stock Traders Daily
Bioventus CEO to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan
Principal Financial Group Inc. Takes Position in Bioventus Inc. (NYSE:BVS) - Defense World
Bioventus Inc. (NYSE:BVS) Shares Acquired by Jane Street Group LLC - Defense World
Bioventus (NYSE:BVS) Trading Down 5.9%Here's Why - MarketBeat
Bioventus: Amply Rewarded For Recent Progress (NASDAQ:BVS) - Seeking Alpha
BVS Stock Gains Post Divestiture of Advanced Rehabilitation Business - MSN
Bioventus completes divestiture of its Advanced Rehabilitation business - Yahoo Finance
Bioventus stock Buy rating reaffirmed, focus shifts to Ultrasonics and international growth - Investing.com India
Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners - The Manila Times
Bioventus Completes $20M Advanced Rehabilitation Business Sale to Accelmed Partners - StockTitan
Bioventus Inc. (NYSE:BVS) Shares Acquired by Barclays PLC - Defense World
Bioventus Inc. (NYSE:BVS) Shares Purchased by Geode Capital Management LLC - Defense World
Franklin Resources Inc. Takes $1.01 Million Position in Bioventus Inc. (NYSE:BVS) - Defense World
Franklin Resources Inc. Makes New Investment in Bioventus Inc. (NYSE:BVS) - MarketBeat
Bioventus Inc. (NYSE:BVS) Stock Position Lifted by State Street Corp - MarketBeat
State Street Corp Has $8.08 Million Stock Holdings in Bioventus Inc. (NYSE:BVS) - Defense World
Bioventus SVP Anthony D'Adamio sells shares worth $61,579 By Investing.com - Investing.com Australia
Bioventus CFO Mark Leonard sells $113,018 in stock By Investing.com - Investing.com Australia
Bioventus CFO Mark Leonard sells $113,018 in stock - Investing.com India
Bioventus SVP Katrina Church sells $26,693 in stock By Investing.com - Investing.com Canada
Katrina J. Church Sells 2,535 Shares of Bioventus Inc. (NYSE:BVS) Stock - MarketBeat
Insider Selling: Bioventus Inc. (NYSE:BVS) CFO Sells $113,018.49 in Stock - MarketBeat
Bioventus SVP Anthony D’Adamio sells shares worth $61,579 By Investing.com - Investing.com Nigeria
Bioventus SVP Anthony D'Adamio sells shares worth $61,579 - Investing.com India
Bioventus SVP Katrina Church sells $26,693 in stock - Investing.com
Shareholder lawsuit ends with $15 million settlement - The Business Journals
Is Bioventus (BVS) Outperforming Other Medical Stocks This Year? - MSN
Medical Device Investors Get Final OK On $15M Deal - Law360
Bioventus Investors Get $15 Million Med Rebate Deal Approved - Bloomberg Law
Bioventus (NYSE:BVS) Upgraded to “Neutral” at JPMorgan Chase & Co. - Defense World
JP Morgan Upgrades Bioventus (BVS) - MSN
Bioventus (NYSE:BVS) Shares Gap UpHere's Why - MarketBeat
Finanzdaten der Bioventus Inc-Aktie (BVS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.38%
1.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):